Title: Can you spare 25mg? Optimizing Benchwork and Computational Approaches to Assess CMC Success

Date/Time: September 11, 2025 at 8:00 AM Pacific / 11:00 AM Eastern

Summary:  Drug discovery scientists often believe gram scale quantities of API are required to determine CMC properties like solubility, oral absorption, salt selection, and formulation strategy. But in this webinar, Crystal Pharmatech Co-Founder and Chief Business Officer Robert Wenslow will present advanced computational approaches and a focused lab component to provide you with development risks with only 25mg of material. This allows developability to truly mainstream into late lead op and significantly enhance POS for Phase I candidates.

Attendees will have the chance to get their questions answered during the live Q&A at the end of the presentation. Don’t miss out on this opportunity to learn from an industry expert—register now.

Presenter: Crystal Pharmatech Co-Founder and Chief Business Officer, Robert Wenslow
Moderator: Simulations Plus Senior Director, Business Development, Arlene Padron